<< FDA approves new version of St. Jude Medical internet-based remote care system for implanted medical devices | District of Columbia HIV/AIDS prevalence at 3%, report says >>
Read in | English | עִבְרִית

ATCC develops and isolates novel avian flu monoclonal antibodies

Published on March 16, 2009 at 7:06 PM · No Comments

ATCC (American Type Culture Collection) researchers have developed a panel of novel monoclonal antibodies (mAbs) against avian influenza viruses. These antibodies could lead to a rapid diagnostic test for the infection, ATCC announced today. The organization has filed a patent covering the development of these novel antibodies.

These monoclonal antibodies (mAbs) specifically target the hemagglutinin molecule of three avian influenza A subtypes. Historically, these target viruses have caused lethal outbreaks in poultry. If they acquire the ability to be transmitted efficiently from human to human, they could potentially cause a worldwide pandemic.

"Given the potential for H5, H7 and H9 avian influenza to jump species and cause a public health crisis, we focused our efforts on developing reagents to detect avian influenza strains which have the potential to cause pandemic disease in humans," explained Cohava Gelber, PhD/MBA, ATCC Chief Science and Technology Officer.

The antibody-based diagnostic test that is being developed by ATCC is designed to provide information about the virus subtype, a capability that is not currently found in existing rapid influenza diagnostics. Using a nasal swab, healthcare practitioners could quickly distinguish between a strain of seasonal influenza that is already circulating in the human population and an emerging strain of bird flu, to which humans have no pre-existing immunity.

Although the ATCC research was targeted at a rapid diagnostic test for human infections, it may also be useful for detecting the virus in domestic poultry and wild aquatic birds, the natural reservoirs for influenza viruses.

"Our research represents a major step toward developing a surveillance tool that the public health community can use to protect the population from avian flu and from a possible flu pandemic," said John Simms, PhD, ATCC Product Development Scientist and antibody project leader.

Historical evidence suggests that influenza pandemics have occurred at 10- to 40-year intervals since the 1600s. Most of these pandemics originated in Asia. Three such pandemics have occurred in the 20th century. The most devastating of these was the Spanish Flu pandemic of 1918-1919, which killed an estimated 50 million people across the globe.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading